Do colored cells in risk matrices affect decision-making and risk perception? Insights from randomized controlled studies | 10.1111/risa.14091 | 2023 |
COVID-19 risk perception and hoax beliefs in the US immediately before and after the announcement of President Trump's diagnosis | 10.1098/rsos.212013 | 2022 |
Investigating the presentation of uncertainty in an icon array: A randomized trial | 10.1016/j.pecinn.2021.100003 | 2022 |
Making BRCA1 genetic test reports easier to understand through user-centered design: A randomized trial | 10.1016/j.gim.2022.04.016 | 2022 |
The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis | 10.1371/journal.pone.0275321 | 2022 |
The effects of communicating scientific uncertainty on trust and decision making in a public health context | No DOI available. | 2022 |
Expert elicitation on the relative importance of possible SARS-CoV-2 transmission routes and the effectiveness of mitigations. | 10.1136/bmjopen-2021-050869 | 2021-12 |
The effects of President Trump’s COVID-19 diagnosis on hoax beliefs and risk perceptions of the virus in the U.S. | 10.31234/osf.io/frxt8 | 2021-12 |
Visualising SARS-CoV-2 transmission routes and mitigations. | 10.1136/bmj-2021-065312 | 2021-12 |
The effects of quality of evidence communication on perception of public health information about COVID-19: Two randomised controlled trials. | 10.1371/journal.pone.0259048 | 2021-11 |
Clinical Impact of the Predict Prostate Risk Communication Tool in Men Newly Diagnosed with Nonmetastatic Prostate Cancer: A Multicentre Randomised Controlled Trial. | 10.1016/j.eururo.2021.08.001 | 2021-09 |
How People Understand Risk Matrices, and How Matrix Design Can Improve their Use: Findings from Randomized Controlled Studies. | 10.1111/risa.13822 | 2021-09 |
The effects of communicating uncertainty around statistics on public trust: an international study | 10.1101/2021.09.27.21264202 | 2021-09 |
How Accurate Are Accuracy-Nudge Interventions? A Preregistered Direct Replication of Pennycook et al. (2020). | 10.1177/09567976211024535 | 2021-06 |
Redevelopment of the Predict: Breast Cancer website and recommendations for developing interfaces to support decision-making. | 10.1002/cam4.4072 | 2021-06 |
How do the UK public interpret COVID-19 test results? Comparing the impact of official information about results and reliability used in the UK, USA and New Zealand: a randomised controlled trial. | 10.1136/bmjopen-2020-047731 | 2021-05 |
How well did experts and laypeople forecast the size of the COVID-19 pandemic? | 10.1371/journal.pone.0250935 | 2021-05 |
Communicating personalized risks from COVID-19: guidelines from an empirical study. | 10.1098/rsos.201721 | 2021-04 |
Effect of Information about COVID-19 Vaccine Effectiveness and Side Effects on Behavioural Intentions: Two Online Experiments | 10.3390/vaccines9040379 | 2021-04 |
The effects of quality of evidence communication on perception of public health information about COVID-19: two randomised controlled trials | 10.1101/2021.04.07.21255010 | 2021-04 |
The adverse effects of bisphosphonates in breast cancer: A systematic review and network meta-analysis. | 10.1371/journal.pone.0246441 | 2021-02 |
Clinical impact of the <i>Predict</i> Prostate risk communication tool in men newly diagnosed with non-metastatic prostate cancer: a multi-centre randomised controlled trial | 10.1101/2021.01.24.21249948 | 2021-01 |
COVID-19 risk perception: a longitudinal analysis of its predictors and associations with health protective behaviours in the United Kingdom | 10.1080/13669877.2021.1890637 | 2021 |
Correlates of intended COVID-19 vaccine acceptance across time and countries: Results from a series of cross-sectional surveys | 10.1136/bmjopen-2020-048025 | 2021 |
Effect of information format on intentions and beliefs regarding diagnostic imaging for non-specific low back pain: A randomised controlled trial in members of the public | 10.1016/j.pec.2020.08.021 | 2021 |
How do the public interpret COVID-19 swab test results? Comparing the impact of official information about results and reliability used in the UK, US and New Zealand: a randomised, controlled trial | 10.1101/2020.12.04.20243840 | 2020-12 |
Predictors of COVID-19 vaccine acceptance across time and countries | 10.1101/2020.12.09.20246439 | 2020-12 |
Five rules for evidence communication. | 10.1038/d41586-020-03189-1 | 2020-11 |
Communicating personalised risks from COVID-19: guidelines from an empirical study | 10.1101/2020.10.05.20206961 | 2020-10 |
Susceptibility to misinformation about COVID-19 around the world. | 10.1098/rsos.201199 | 2020-10 |
Teaching clinicians shared decision making and risk communication online: an evaluation study. | 10.1136/bmjebm-2020-111521 | 2020-09 |
Communicating risks and benefits to cardiology patients. | 10.1136/heartjnl-2020-317593 | 2020-08 |
The effects of communicating uncertainty on public trust in facts and numbers. | 10.1073/pnas.1913678117 | 2020-03 |
Recommendations for designing genetic test reports to be understood by patients and non-specialists. | 10.1038/s41431-020-0579-y | 2020-02 |
Making prognostic algorithms useful in shared decision-making: Patients and clinicians’ requirements for the Predict:Breast Cancer interface | 10.1101/2020.11.16.20232348 | 2020 |
Risk communication in tables versus text: A registered report randomized trial on 'fact boxes' | 10.1098/rsos.190876 | 2020 |
Risk perceptions of COVID-19 around the world | 10.1080/13669877.2020.1758193 | 2020 |
Correction: Creating genetic reports that are understood by nonspecialists: a case study. | 10.1038/s41436-019-0663-2 | 2019-09 |
Creating genetic reports that are understood by nonspecialists: a case study. | 10.1038/s41436-019-0649-0 | 2019-09 |
How to communicate evidence to patients. | 10.1136/dtb.2019.000008 | 2019-08 |
Communicating uncertainty about facts, numbers and science. | 10.1098/rsos.181870 | 2019-05 |
Communicating health risks in science publications: time for everyone to take responsibility. | 10.1186/s12916-018-1194-4 | 2018-11 |
Winners and losers: communicating the potential impacts of policies | 10.1057/s41599-018-0121-9 | 2018-06 |
Communicating risk in primary care: what the Academy of Medical Sciences' report means in practice. | 10.3399/bjgp17x691793 | 2017-08 |
PROMIS - Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer | 10.1016/j.cct.2015.02.008 | 2015 |
First authentic capture of a coelacanth, Latimeria chalumnae (Pisces: Latimeriidae), off Madagascar | No DOI available. | 1996 |
The evolution of self-concealed ovulation in humans | 10.1016/0162-3095(95)00071-2 | 1995 |